Subscribe
eNewsletter
Ready to get certified?
Free CDCES Coach App
Download
Free Med Pocket Cards
eNewsletter
Free CDCES Coach App
Free Med Pocket Cards
“I’ve managed my diabetes for years, but ever since starting cancer treatment, my blood glucose has been all over the place. I don’t know what I am doing wrong.” As … Continue reading Decoding the Cancer-Diabetes Connection
We sat down with Diana Isaacs, PharmD, BCACP, CDCES, BC-ADM, FADCES, FCCP – the 2026 ADA Outstanding Educator of the Year – to explore her insights on the current state … Continue reading Interview with Diana Isaacs – ADA Outstanding Educator of the Year
By Lilly Mees LMSW, CDCES A study of 893 individuals found that those with type 2 diabetes (T2D) had significantly lower growth mindsets toward blood glucose control and lower self-efficacy toward … Continue reading Does Self-Efficacy (A Person’s Confidence or Belief) Matter to Those with Diabetes?
Celebrations are in order! June is Pride Month – a time to honor diversity, inclusion, and the freedom to be authentically ourselves. It’s also a special month for another reason … Continue reading June 2026 e-News | PCOS Renamed & PocketCard Updates
For last week’s practice question, we quizzed participants on A1C 7.4% & struggling with hypoglycemia. 83% of respondents chose the best answer. We want to clarify and share this important … Continue reading Rationale of the Week | A1C 7.4% & Struggling with Hypoglycemia
Author: Christine Craig, MS, RDN, CDCES Founder: Nutrition for Daily Living Did you know that people with diabetes are more likely to experience hearing loss? At the June 2026 American Diabetes … Continue reading ASL and Equitable Diabetes Care
JL has T2DM, and heart failure with preserved ejection fraction (HFpEF). Is currently on Metformin 1000mg BID and empagliflozin 25mg daily. Their A1C is 8.1%. Which agent should be added … Continue reading Question of the Week | What’s the best medication for HFpEF?
For last week’s practice question, we quizzed participants on who would most benefit from metformin therapy. 63.26% of respondents chose the best answer. We want to clarify and share this … Continue reading Rationale of the Week | Who would most benefit from metformin therapy?